Search

Your search keyword '"Bauer, D."' showing total 4,167 results

Search Constraints

Start Over You searched for: Author "Bauer, D." Remove constraint Author: "Bauer, D."
4,167 results on '"Bauer, D."'

Search Results

1. First Dark Matter Search Results from the LUX-ZEPLIN (LZ) Experiment

2. A next-generation liquid xenon observatory for dark matter and neutrino physics

3. First Dark Matter Search Results from the LUX-ZEPLIN (LZ) Experiment

4. Effective Field Theory Analysis of CDMSlite Run 2 Data

5. Investigating the sources of low-energy events in a SuperCDMS-HVeV detector

6. A Strategy for Low-Mass Dark Matter Searches with Cryogenic Detectors in the SuperCDMS SNOLAB Facility

7. A Next-Generation Liquid Xenon Observatory for Dark Matter and Neutrino Physics

8. Ionization yield measurement in a germanium CDMSlite detector using photo-neutron sources

9. Cosmogenic production of $^{37}$Ar in the context of the LUX-ZEPLIN experiment

10. Cosmogenic production of Ar37 in the context of the LUX-ZEPLIN experiment

11. A Next-Generation Liquid Xenon Observatory for Dark Matter and Neutrino Physics

12. Erratum to: The LUX-ZEPLIN (LZ) radioactivity and cleanliness control programs

13. A generalization of a theorem of Nash-Williams

14. Projected sensitivity of the LUX-ZEPLIN (LZ) experiment to the two-neutrino and neutrinoless double beta decays of $^{134}$Xe

15. Projected sensitivities of the LUX-ZEPLIN (LZ) experiment to new physics via low-energy electron recoils

16. Phase-of-the-phase electron momentum spectroscopy on single metal atoms in helium nanodroplets

17. Enhancing the sensitivity of the LUX-ZEPLIN (LZ) dark matter experiment to low energy signals

18. Projected sensitivity of the LUX-ZEPLIN experiment to the two-neutrino and neutrinoless double β decays of Xe134

19. Projected sensitivities of the LUX-ZEPLIN experiment to new physics via low-energy electron recoils

20. Design and Characterization of a Phonon-Mediated Cryogenic Particle Detector with an eV-Scale Threshold and 100 keV-Scale Dynamic Range

21. Constraints on Lightly Ionizing Particles from CDMSlite

22. Numerical time-of-flight analysis of the strong-field photoeffect

23. Light Dark Matter Search with a High-Resolution Athermal Phonon Detector Operated Above Ground

24. The LUX-ZEPLIN (LZ) radioactivity and cleanliness control programs

25. Bound-free pair production in relativistic nuclear collisions from the NICA to the HE LHC colliders

26. Constraints on low-mass, relic dark matter candidates from a surface-operated SuperCDMS single-charge sensitive detector

27. Simulations of Events for the LUX-ZEPLIN (LZ) Dark Matter Experiment

28. Constraints on dark photons and axion-like particles from SuperCDMS Soudan

29. Revealing laser-coherent electron features using phase-of-the-phase spectroscopy

30. The LUX-ZEPLIN (LZ) Experiment

31. Projected sensitivities of the LUX-ZEPLIN (LZ) experiment to new physics via low-energy electron recoils

32. Simulations of events for the LUX-ZEPLIN (LZ) dark matter experiment

33. Enhancing the sensitivity of the LUX-ZEPLIN (LZ) dark matter experiment to low energy signals

34. The LUX-ZEPLIN (LZ) radioactivity and cleanliness control programs

36. Projected WIMP sensitivity of the LUX-ZEPLIN dark matter experiment

37. The LUX-ZEPLIN (LZ) experiment

38. COMET Phase-I Technical Design Report

39. Dupilumab Does Not Impact Blood Eosinophil Levels in Patients With Moderate-to-Severe COPD and Type 2 Inflammation: From the Phase 3 Boreas Trial

40. Dupilumab Improves Pre-bronchodilator Lung Function Measures in Patients With Chronic Obstructive Pulmonary Disease (COPD) With Type 2 Inflammation: Data From the Phase 3 Boreas Trial

41. Dupilumab Increases the Proportion of Patients With Fractional Exhaled Nitric Oxide Levels <20 ppb Over Time in Patients With Moderate-to-Severe Chronic Obstructive Pulmonary Disease and Type 2 Inflammation: From Phase 3 Boreas

42. Dupilumab Improves Post-bronchodilator Lung Function in Patients With Moderate-to-Severe Chronic Obstructive Pulmonary Disease (COPD) With Type 2 Inflammation: Data From the Phase 3 Boreas Trial

43. In the Phase 3 Boreas Trial, Baseline Blood Eosinophils and Baseline Fractional Exhaled Nitric Oxide Levels Predict the Response to Dupilumab in Patients With Moderate-to-Severe Chronic Obstructive Pulmonary Disease and Type 2 Inflammation

44. Efficacy and Safety of Dupilumab in Patients With Moderate-to-Severe COPD and Type 2 Inflammation: Phase 3 NOTUS Trial

45. In The Phase 3 Boreas Trial, Dupilumab Reduced FeNO Levels Over Time in Patients With Moderate-to-Severe COPD With Type 2 Inflammation

46. Search for Low-Mass Dark Matter with CDMSlite Using a Profile Likelihood Fit

47. Two-color phase-of-the-phase spectroscopy with circularly polarized laser pulses

48. Production Rate Measurement of Tritium and Other Cosmogenic Isotopes in Germanium with CDMSlite

49. First Dark Matter Constraints from a SuperCDMS Single-Charge Sensitive Detector

50. Nuclear-recoil energy scale in CDMS II silicon dark-matter detectors

Catalog

Books, media, physical & digital resources